World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
42991
World Ranking
15360
National Ranking
7746

Overview

Jorge A. Marrero is affiliated with the University of Pennsylvania in the United States. The primary area of research focuses on Medicine, with a specialization across hepatology, epidemiology, oncology, cancer research, and cardiology and cardiovascular medicine.

Their research covers major topics including liver disease diagnosis and treatment, hepatocellular carcinoma treatment and prognosis, liver disease and transplantation, cancer related to lipids and metabolism, hepatitis C virus research, hepatitis B virus studies, as well as pancreatic and hepatic oncology research.

Frequent publication venues for their work include:

  • Gastroenterology
  • Hepatology
  • Clinical Gastroenterology and Hepatology
  • Journal of Hepatology
  • Liver Transplantation

Notable recent publications by Jorge A. Marrero include:

  • AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma, 2023, Hepatology
  • Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference, 2020, Hepatology
  • HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis, 2022, Journal of Hepatology
  • Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis, 2020, Hepatology
  • GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis, 2021, Hepatology

Collaborations have been established with several frequent co-authors, including:

  • Amit G. Singal
  • Neehar D. Parikh
  • Nicole E. Rich
  • Fasiha Kanwal
  • Adam C. Yopp

Best Publications

  • A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C

    Chun-Tao Wai;Joel K. Greenson;Robert J. Fontana;John D. Kalbfleisch

  • Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

    Jorge A. Marrero;Laura M. Kulik;Claude B. Sirlin;Andrew X. Zhu

  • AASLD guidelines for the treatment of hepatocellular carcinoma

    Julie K. Heimbach;Laura M. Kulik;Richard S. Finn;Claude B. Sirlin

  • NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

    Al B Benson;Thomas A. Abrams;Edgar Ben-Josef;P. Mark Bloomston

  • Diagnosis and treatment of hepatocellular carcinoma.

    Hashem B. El-Serag;Jorge A. Marrero;Lenhard Rudolph;K. Rajender Reddy

  • Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

    A. Singal;M. L. Volk;A. Waljee;R. Salgia

  • Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

    Kristina Tzartzeva;Joseph Obi;Nicole E. Rich;Neehar D. Parikh

  • Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

    Jordi Bruix;Jean Luc Raoul;Morris Sherman;Vincenzo Mazzaferro

  • α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

    Jorge A. Marrero;Ziding Feng;Yinghui Wang;Mindie H. Nguyen

  • NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States

    Jorge A. Marrero;Robert J. Fontana;Grace L. Su;Hari S. Conjeevaram

  • GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma

    Jorge A. Marrero;Patrick R. Romano;Olga Nikolaeva;Laura Steel

  • Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.

    Silvia Cermelli;Anna Ruggieri;Anna Ruggieri;Jorge A. Marrero;George N. Ioannou

  • Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma

    Jorge A. Marrero;Robert J. Fontana;Sherry Fu;Hari S. Conjeevaram

  • Virologic response and resistance to adefovir in patients with chronic hepatitis B

    Scott K. Fung;Hee Bok Chae;Robert J. Fontana;Hari Conjeevaram

  • Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients☆

    Jorge A. Marrero;Grace L. Su;Wei Wei;Dawn Emick

  • ACG Clinical Guideline: The Diagnosis and Management of Focal Liver Lesions

    Jorge A. Marrero;Joseph Ahn;K. Rajender Reddy

  • Comparison of imputation methods for missing laboratory data in medicine

    Akbar K. Waljee;Ashin Mukherjee;Amit G. Singal;Yiwei Zhang

  • Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study

    Jorge A. Marrero;Masatoshi Kudo;Alan P. Venook;Sheng Long Ye

  • The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.

    Amit G Singal;Hema Manjunath;Adam C Yopp;Muhammad S Beg

  • Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

    Sufen Shang;Amelie Plymoth;Amelie Plymoth;Shaokui Ge;Ziding Feng

Frequent Co-Authors

Amit G. Singal
Amit G. Singal The University of Texas Southwestern Medical Center
Ziding Feng
Ziding Feng Fred Hutchinson Cancer Research Center
Anand Mehta
Anand Mehta Medical University of South Carolina
Lewis R. Roberts
Lewis R. Roberts Mayo Clinic
Riccardo Lencioni
Riccardo Lencioni University of Pisa
Timothy M. Block
Timothy M. Block Drexel University
Masatoshi Kudo
Masatoshi Kudo Kindai University
Yujin Hoshida
Yujin Hoshida The University of Texas Southwestern Medical Center
David M. Lubman
David M. Lubman University of Michigan–Ann Arbor
Hashem B. El-Serag
Hashem B. El-Serag Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always mean attending medical school. Many students consider related online degrees to enter healthcare fields with flexible and affordable options. For example, online pharmacy programs enable you to work towards becoming a pharmacist from anywhere, saving on costs and relocating.

If you’re interested in the administrative side of healthcare, earning an RHIA credential opens doors to health information management roles. There are flexible rhia certification programs online to help you gain these valuable skills.

Another popular pathway is medical coding and billing. With growing demand for these professionals, many students look for affordable medical billing and coding certification cost options that don’t compromise on quality.

Nursing is another rewarding route. If you want to advance your nursing career, researching the cheapest np school choices can help you become a nurse practitioner without overwhelming debt.

Best Scientists Citing Jorge A. Marrero

Trending Scientists

Recently Published Articles